146954-76-9

Basic information

• Product Name: N4-Benzoyl-2'-deoxy-2'-fluorocytidine
• Synonyms: N4-Benzoyl-2'-deoxy-2'-fluorocytidine;N-Benzoyl-2'-deoxy-2'-fluorocytidine
• CAS NO: 146954-76-9
• Molecular Formula: C₁₆H₁₆FN₃O₅
• Molecular Weight: 349.3137432
• Mol File: 146954-76-9.mol
• Article Data: 16

Chemical Properties

• Appearance: /
• Density: 1.56±0.1 g/cm3(Predicted)
• PKA: 8.52±0.20(Predicted)
• CAS DataBase Reference: N4-Benzoyl-2'-deoxy-2'-fluorocytidine(CAS DataBase Reference)
• NIST Chemistry Reference: N4-Benzoyl-2'-deoxy-2'-fluorocytidine(146954-76-9)
• EPA Substance Registry System: N4-Benzoyl-2'-deoxy-2'-fluorocytidine(146954-76-9)

Safety Data

• Hazardous Substances Data: 146954-76-9(Hazardous Substances Data)

Usage

General Description

N4-Benzoyl-2'-deoxy-2'-fluorocytidine is a chemical compound that belongs to the class of nucleoside analogues. It is a modified form of cytidine, a nucleoside found in DNA and RNA. N4-Benzoyl-2'-deoxy-2'-fluorocytidine is characterized by the substitution of a hydrogen atom with a fluorine atom at the 2' position and a benzoyl group at the N4 position of the cytidine molecule. N4-Benzoyl-2'-deoxy-2'-fluorocytidine has shown promising antiviral activity, particularly against viruses such as HIV and hepatitis B virus. Its unique structure gives it the potential to disrupt viral replication and could be a promising candidate for the development of new antiviral drugs.

Upstream product

• 69304-43-4 1-[3,5-O-(1,1,3,3-tetraisopropyldisiloxane-1,3-diyl)-β-D-ribofuranosyl]-N⁴-benzoylcytosine 
• 13089-48-0 N₄-benzoylcytidine 
• 93-97-0 benzoic acid anhydride 
• 65-46-3 CYTIDINE 
• 10212-20-1 2'-deoxy-2'-fluorocytidine 
• 196928-90-2 Acetic acid (2R,3R,4R,5R)-2-acetoxymethyl-4-fluoro-5-[4-(3-nitro-[1,2,4]triazol-1-yl)-2-oxo-2H-pyrimidin-1-yl]-tetrahydro-furan-3-yl ester 
• 56287-17-3 2'-deoxy-2'-fluorouridine 
• 10212-13-2 3’,5’-O-acetyl-2’-deoxy-2’-fluorouridine 

Downstream Products

• 146954-77-0 N⁴-benzoyl-5'-O-(4,4'-dimethoxytrityl)-2'-fluoro-2'-deoxycytidine 
• 161442-19-9 N⁴-benzoyl-2'-deoxy-2'-fluoro-5'-O-(4,4'-dimethoxytrityl)cytidine 3'-(β-cyanoethyl N,N-diisopropylphosphoramidite) 
• 177086-37-2 C₃₀H₃₀FN₃O₆ 

Relevant articles and documents

Synthesis method for azvudine

The invention discloses a synthesis method for azvudine. The method comprises the following steps of carrying out a hydroxyl substitution reaction on a compound 4 and an iodine elementary substance toobtain a compound 5, carrying out an elimination reaction on an iodo group in the compound 5 to obtain a compound 6, reacting the compound 6 with azide under the catalysis of ICl to obtain a compound7, carrying out an iodine substitution reaction on the compound 7 and carboxylic acid to obtain a compound 8, and carrying out an amino and hydroxyl deprotection reaction on the compound 8 to obtaina compound 9, namely the alzvudine. Compared with an existing synthesis method, the synthesis method has the advantages of short synthesis route, shortened reaction time, mild reaction conditions andeasily controlled reaction process, can be used for preparing the alzvudine with the lower cost, and has a very good application prospect.

SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF

Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a norovirus, with a nucleoside, a nucleotide and an analog thereof.

Modulation of CEACAM1 expression

Compounds, compositions and methods are provided for modulating the expression of CEACAM1. The compositions comprise oligonucleotides, targeted to nucleic acid encoding CEACAM1. Methods of using these compounds for modulation of CEACAM1 expression and for diagnosis and treatment of disease associated with expression of CEACAM1 are provided.